Clinical Trial

Resveratrol Effects on Inflammatory Biomarkers and Cardiometabolic Parameters.

Study acronym: RESINCA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effect of the supplementation of grape pomace bars enriched in resveratrol on inflammatory biomarkers and cardiometabolic parameters in community-dwelling adults
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08-31 -> 2026-11-30 2026-05-20
minor Completion pushed: 2026-09-30 -> 2026-12-01 2026-05-20
Trial Details
NCT Number NCT07395921
Lead Sponsor Center for Research and Innovation Viña Concha y Toro
Collaborators: Universidad Católica del Maule
Conditions Inflammation Biomarkers, Cardiometabolic Health Indicators, Antioxidant Status, Inflammation, Antioxidant Capabilities, Inflammaging
Enrollment 75 participants
Start Date 2026-06-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-19